21 participants
A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-10-01
- Start Date:
- 2025-10-06
- Completion:
- 2027-01-01
Conditions
- Metastatic Breast Cancer
- HER2 + Breast Cancer
Interventions
- DRUG
No Results Yet